We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Wabtec
WAB
$49.9B
| $23.3M | 0.03% |
270,811
-10,060
| -4% | -$866K |
|
502
First Horizon
FHN
$12.1B
| $23.3M | 0.03% |
1,431,956
-54,385
| -4% | -$866K |
|
503
Lattice Semiconductor
LSCC
$18.3B
| $23.3M | 0.03% |
359,809
-15
| -0% | -$886 |
|
504
Aecom
ACM
$9.63B
| $23.1M | 0.03% |
366,422
-18,653
| -5% | -$1.19M |
|
505
Cleveland-Cliffs
CLF
$6.98B
| $23.1M | 0.03% |
1,166,817
-51,687
| -4% | -$1.18M |
|
506
Tetra Tech
TTEK
$8.89B
| $23.1M | 0.03% |
773,435
+970
| +0.1% | +$26.6K |
|
|
DAY
507
DELISTED
Dayforce
DAY
| $23M | 0.03% |
204,583
-141,561
| -41% | -$14.9M |
|
|
CTXS
508
DELISTED
Citrix Systems Inc
CTXS
| $23M | 0.03% |
213,786
+195
| +0.1% | +$21.1K |
|
509
United Airlines
UAL
$41.9B
| $22.9M | 0.03% |
482,228
-10,628
| -2% | -$501K |
|
|
SGI
510
Somnigroup International
SGI
$13.6B
| $22.9M | 0.03% |
493,556
+22,669
| +5% | +$990K |
|
511
Baker Hughes
BKR
$62.3B
| $22.9M | 0.03% |
924,699
+41,696
| +5% | +$929K |
|
512
iShares Russell 1000 ETF
IWB
$49.7B
| $22.8M | 0.03% |
94,482
-31,719
| -25% | -$7.89M |
|
|
SYNH
513
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $22.8M | 0.03% |
260,770
-1,229
| -0.5% | -$111K |
|
514
F5
FFIV
$23.5B
| $22.8M | 0.03% |
114,551
-2,661
| -2% | -$532K |
|
|
Y
515
DELISTED
Alleghany Corp
Y
| $22.7M | 0.03% |
36,402
-1,365
| -4% | -$901K |
|
516
Viatris
VTRS
$19B
| $22.7M | 0.03% |
1,677,437
-61,780
| -4% | -$877K |
|
517
Genpact
G
$6.13B
| $22.7M | 0.03% |
478,230
-15,905
| -3% | -$790K |
|
518
Alliant Energy
LNT
$18B
| $22.7M | 0.03% |
405,393
-6,220
| -2% | -$368K |
|
|
AZPN
519
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $22.6M | 0.03% |
183,870
-1,611
| -0.9% | -$198K |
|
520
Iron Mountain
IRM
$36.3B
| $22.6M | 0.03% |
519,472
+4,489
| +0.9% | +$202K |
|
521
Sunrun
RUN
$2.24B
| $22.6M | 0.03% |
512,608
+52,926
| +12% | +$2.53M |
|
522
First American
FAF
$7.67B
| $22.5M | 0.03% |
335,038
-6,356
| -2% | -$425K |
|
523
Brown-Forman Class B
BF.B
$13B
| $22.4M | 0.03% |
334,011
-632
| -0.2% | -$44.7K |
|
524
Gentex
GNTX
$4.96B
| $22.3M | 0.03% |
675,206
-104,618
| -13% | -$3.38M |
|
525
SolarEdge
SEDG
$1.99B
| $22.2M | 0.03% |
83,653
-61
| -0.1% | -$16.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.